Related Experiment Video
Updated: Apr 17, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
The target-specific oral anticoagulants: practical considerations
1University of Washington, Seattle, WA.
Abstract:
More than 4 years have passed since the first approval of a target-specific oral anticoagulant (TSOAC) in the United States, and the number of clinicians who have prescribed (or considered prescribing) one or more of these medications is increasing. Although these agents may, in properly selected patients, offer advantages over more traditional therapies, their lack of familiarity can be intimidating. Clinicians who are prescribing the TSOACs face a number of management questions not definitively answered by the registration trials. This chapter reviews some of these situations, including updated information on the periprocedural management of TSOACs and the latest evidence about how to best measure TSOAC effect. The lack of an antidote and other considerations that may be relevant when deciding between newer and more traditional anticoagulant medications are also discussed.
Insights
Target-specific oral anticoagulants (TSOACs) offer advantages but require careful management. This review addresses clinical questions regarding TSOACs, including periprocedural care and monitoring, to aid prescribing decisions.
Area of Science:
- Pharmacology and Therapeutics
- Cardiovascular Medicine
Background:
- Target-specific oral anticoagulants (TSOACs) are increasingly prescribed.
- Clinicians face management questions not fully addressed by initial trials.
- Familiarity with TSOACs is growing, but challenges remain.
Purpose of the Study:
- To review current management questions for TSOACs.
- To provide updated information on periprocedural TSOAC management.
- To discuss methods for measuring TSOAC effect and compare them with traditional anticoagulants.
Main Methods:
- Literature review of recent evidence and clinical trial data.
- Synthesis of information on periprocedural management strategies.
- Discussion of monitoring techniques and antidote considerations.
Main Results:
- Updated guidance on periprocedural management of TSOACs is available.
- Evidence on optimal methods for measuring TSOAC effect is evolving.
- Key considerations for choosing between TSOACs and traditional anticoagulants are highlighted.
Conclusions:
- TSOACs present management challenges requiring updated clinical guidance.
- Further evidence is needed for optimal TSOAC monitoring and periprocedural care.
- Informed decision-making between TSOACs and traditional anticoagulants is crucial for patient safety.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Venous Thrombosis IV: Nursing Management
Therapeutic Index

